drugset / Trial / NCT04614350

Pilot Study for Healing and Safety Outcomes in Gingival Recession

NCT04614350

Phase 4 Completed 10 enrolled McGuire Institute CellTherX · collab
RandomizedParallel-groupOpen-labelTreatment

Summary

Prospective, randomized, within subjects-controlled design

Timeline

Start
2020-10-30
Primary completion
2022-02-25
Completion
2022-06-30

Drugs

EvaluationDrugModalityDoseRoute
Comparator AlloDerm Other / unclassified
Subject Markman Biologics Microsurfaced ADM Unknown

Indications